Standout Papers

Updated Clinical Classification of Pulmonary Hypert... 2002 2026 2010 2018 2.5k
  1. Updated Clinical Classification of Pulmonary Hypertension (2013)
    Gérald Simonneau, Michael Α. Gatzoulis et al. Journal of the American College of Cardiology
  2. Haemodynamic definitions and updated clinical classification of pulmonary hypertension (2018)
    Gérald Simonneau, David Montani et al. European Respiratory Journal
  3. Bosentan Therapy for Pulmonary Arterial Hypertension (2002)
    Lewis J. Rubin, David B. Badesch et al. New England Journal of Medicine
  4. Updated Clinical Classification of Pulmonary Hypertension (2009)
    Gérald Simonneau, Ivan M. Robbins et al. Journal of the American College of Cardiology
  5. Pulmonary Arterial Hypertension in France (2006)
    Marc Humbert, Olivier Sitbon et al. American Journal of Respiratory and Critical Care Medicine
  6. Clinical classification of pulmonary hypertension (2004)
    Gérald Simonneau, Nazzareno Galiè et al. Journal of the American College of Cardiology
  7. Treatment of Pulmonary Arterial Hypertension (2004)
    Marc Humbert, Olivier Sitbon et al. New England Journal of Medicine
  8. Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (1995)
    Laurent Brochard, Jordi Mancebo et al. New England Journal of Medicine
  9. A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis (1998)
    Hervé Decousus, Alain Leizorovicz et al. New England Journal of Medicine
  10. Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension (2002)
    Gérald Simonneau, Robyn J. Barst et al. American Journal of Respiratory and Critical Care Medicine
  11. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension (2002)
    Olivier Sitbon, Marc Humbert et al. Journal of the American College of Cardiology
  12. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension (2013)
    Tomás Pulido, Richard N. Channick et al. New England Journal of Medicine
  13. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (2013)
    Hossein Ardeschir Ghofrani, Andrea Maria D’Armini et al. New England Journal of Medicine
  14. Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home (1996)
    Maria M.W. Koopman, Paolo Prandoni et al. New England Journal of Medicine
  15. Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension (1996)
    Lucien Abenhaim, Yola Moride et al. New England Journal of Medicine
  16. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension (2005)
    Olivier Sitbon, Marc Humbert et al. Circulation
  17. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension (2015)
    Nazzareno Galiè, Joan Albert Barberà et al. New England Journal of Medicine
  18. Selexipag for the Treatment of Pulmonary Arterial Hypertension (2015)
    Olivier Sitbon, Richard N. Channick et al. New England Journal of Medicine
  19. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial (2008)
    Nazzareno Galiè, LJ Rubin et al. The Lancet
  20. Medical Therapy For Pulmonary Arterial Hypertension (2004)
    David B. Badesch, Steve Abman et al. CHEST Journal
  21. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. (1995)
    Marc Humbert, Gianpaola Monti et al. American Journal of Respiratory and Critical Care Medicine
  22. A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism (1997)
    Gérald Simonneau, Hervé Sors et al. New England Journal of Medicine
  23. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry (2011)
    Eckhard Mayer, David P. Jenkins et al. Journal of Thoracic and Cardiovascular Surgery
  24. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension (2017)
    Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal
  25. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension (2015)
    Benoît Ranchoux, Fabrice Antigny et al. Circulation
  26. Increased plasma serotonin in primary pulmonary hypertension (1995)
    Jean‐Marie Launay, François Brenot et al. The American Journal of Medicine
  27. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension (2013)
    Marius M. Hoeper, Robyn J. Barst et al. Circulation
  28. The pathophysiology of chronic thromboembolic pulmonary hypertension (2017)
    Gérald Simonneau, Adam Torbicki et al. European Respiratory Review

Immediate Impact

4 by Nobel laureates 4 from Science/Nature 146 standout
Sub-graph 1 of 13

Citing Papers

Systemic sclerosis
2022 Standout
Acute Pulmonary Embolism
2022 Standout
66 intermediate papers

Works of Gérald Simonneau being referenced

Diagnostic value of D-dimer in patients with suspected pulmonary embolism: Results from a multicentre outcome study
2006
High Prevalence of Detectable Deep Venous Thrombosis in Patients With Acute Pulmonary Embolism
1999
and 100 more

Author Peers

Author Last Decade Papers Cites
Gérald Simonneau 46462 29459 9772 473 56.8k
Marc Humbert 46488 21000 7849 917 58.9k
Lewis J. Rubin 30667 21340 5884 302 36.7k
Hossein Ardeschir Ghofrani 26892 17252 4363 554 33.5k
Olivier Sitbon 23975 14275 5242 376 26.6k
Robyn J. Barst 29750 20693 6415 237 33.3k
Nazzareno Galiè 23340 16813 4581 369 26.7k
Marius M. Hoeper 20306 13716 3547 401 25.0k
Victor F. Tapson 14917 15502 2771 319 28.6k
Michael D. McGoon 21995 17784 3738 168 27.8k
David B. Badesch 22563 14761 4354 162 25.1k

All Works

Loading papers...

Rankless by CCL
2026